Significant Ownership of SAMLYN CAPITAL, LLC

Signature - Title
By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, /s/ Robert Pohly* - Robert Pohly / Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by SAMLYN CAPITAL, LLC.

Notify me when SAMLYN CAPITAL, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of SAMLYN CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PCT PureCycle Technologies, Inc. Common Stock, par value $0.001 per share 7.2% $179,440,876 -$40,162,309 13,645,694 -18.3% Samlyn Capital, LLC 30 Sep 2025
VINP Vinci Partners Investments Ltd. Class A Common Shares, par value US$0.00005 per share 4.8% $24,085,811 -$36,097 2,356,733 -0.15% SAMLYN CAPITAL, LLC 31 Mar 2025
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 0% $0 0 Samlyn Capital, LLC 31 Dec 2024
CRVS Corvus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 -$21,996,708 0 -100% SAMLYN CAPITAL, LLC 30 Jun 2025
NKTR Nektar Therapeutics Common Stock, $0.0001 par value 0% $0 -$4,736,853 0 -100% SAMLYN CAPITAL, LLC 31 Mar 2025

Schedules 13D/G Reported by SAMLYN CAPITAL, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.